- Country: Ukraine
- Summary: Reagents for the Biochemical Analyzer "Cobas Integra 400 Plus" (Closed System) for the Ukrainian Reference Center for Clinical Laboratory Diagnostics and Metrology in 2025: 1. Test for Quantitative...
- UAT Ref No: 130268192
- Deadline: 22 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 149899.93
- Notice Type: Tender
- Document Ref. No.: UA-2025-11-14-001659-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Reagents for the biochemical analyzer "Cobas Integra 400 Plus" (closed system) for the Ukrainian Reference Center for Clinical Laboratory Diagnostics and Metrology in 2025: 1. Test for quantitative determination of creatinine, Gen. 2 (CREJ2), 700 tests, for COBAS INTEGRA 400 Plus, cobas c 311/501/502; 2. Test for quantitative determination of alanine aminotransferase without pyridoxal phosphate activation, 500 tests, for cobas c 311/501/502; 3. Aspartate aminotransferase (ASTL) quantification test, 500 tests, for COBAS INTEGRA 400 Plus, cobas c 311/501/502; 4. Test for quantitative determination of Ξ³-glutamyltransferase, ver.2 (GGT-2), 400 tests, for COBAS INTEGRA 400 Plus, cobas c 311/501/502; 5. Colorimetric test for quantitative determination of lipase (LIPC), 200 tests, for COBAS INTEGRA 400 Plus, cobas c 311/501/502; 6. Test for the quantitative determination of glucose GC, Gen. 3 (GLUC3), 800 tests, for COBAS INTEGRA 400 Plus, cobas c 311/501/502; 7. Test for quantitative determination of alkaline phosphatase, Gen. 2 (ALP2), 400 tests, for COBAS INTEGRA 400 Plus, cobas c 311/501/502; 8. Test for quantitative determination of calcium, Gen. 2 (CA2), 300 tests, for COBAS INTEGRA 400 Plus, cobas c 311/501/502; 9. Test for quantitative determination of phosphorus, ver.2 (PHOS2), 250 tests, for COBAS INTEGRA 400 Plus, cobas c 311/501/502; 10. Π’Π΅ΡΡ Π΄Π»Ρ ΠΊΡΠ»ΡΠΊΡΡΠ½ΠΎΠ³ΠΎ Π²ΠΈΠ·Π½Π°ΡΠ΅Π½Π½Ρ Π·Π°Π»ΡΠ·Π°, ΠΠ΅Π½.2 (IRON2), 200 ΡΠ΅ΡΡΡΠ², Π΄Π»Ρ COBAS INTEGRA 400 Plus, cobas c 311/501/502; 11. Test for quantitative determination of urea/urea nitrogen concentration... Type of purchase: goods Classifier and its relevant code: DK 021:2015: 33600000-6 β Pharmaceutical products are procured through open tenders with special features for 2025 in accordance with the requirements of the Law of Ukraine on Public Procurement dated 12/25/2015. No. 922-VIII (hereinafter - the Law), taking into account Resolution of the Cabinet of Ministers of Ukraine of October 12, 2022 No. 1178 On approval of the specifics of ...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINReagents for the Biochemical Analyzer "Cobas Integra 400 Plus" (Closed System) for the Ukrainian Reference Center for Clinical Laboratory Diagnostics and Metrology in 2025: 1. Test for Quantitative... - Ukraine Tender
The STATE NON-COMMERCIAL ENTERPRISE OKHMATDYT NATIONAL CHILDREN'S SPECIALIZED HOSPITAL OF THE MINISTRY OF HEALTH OF UKRAINE, a Government sector organization in Ukraine, has announced a new tender for Reagents for the Biochemical Analyzer "Cobas Integra 400 Plus" (Closed System) for the Ukrainian Reference Center for Clinical Laboratory Diagnostics and Metrology in 2025: 1. Test for Quantitative.... This tender is published on UkraineTenders under UAT Ref No: 130268192 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-22.
The estimated tender value is UAH 149899.93, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
